Heparanase as a molecular target of cancer chemotherapy

Cancer Science
Siro SimizuHiroyuki Osada

Abstract

Cancer cells require the ability to degrade the extracellular matrix (ECM) in order to turn into invasive and metastatic cancer cells. Many proteases and glycosidases are essential in the process of dissolving the components of the ECM. An endo-beta-D-glucuronidase, heparanase, is capable of specifically degrading one of the ECM components, heparan sulfate, and this activity is associated with the metastatic potential of tumor cells. Since heparanase mRNA is overexpressed in many human tumors (e.g., hepatomas, head and neck tumors, and esophageal carcinomas), the mechanisms regulating the activity of heparanase should be clarified; considering the possible role of heparanase in cancer, the development of heparanase inhibitors would appear to be advantageous. This review will focus on recent findings that have contributed to the characterization of heparanase and to the elucidation of the transcriptional regulation of heparanase mRNA expression, as well as the development of heparanase inhibitors.

References

Dec 15, 1975·Biochemical and Biophysical Research Communications·M HöökA Oldberg
Sep 15, 1995·Structure·G Davies, B Henrissat
Jul 16, 1999·Biochemical and Biophysical Research Communications·P H KussieP Bohlen
Aug 14, 1999·The Journal of Biological Chemistry·M Toyoshima, M Nakajima
Oct 9, 1999·The Journal of Biological Chemistry·M B FairbanksR L Heinrikson
Nov 5, 1999·Seminars in Cancer Biology·M Toyota, J P Issa
Jun 29, 2000·Annual Review of Biochemistry·M BernfieldM Zako
Aug 1, 2000·Trends in Biochemical Sciences·L A DempseyJ L Platt
Oct 12, 2000·Biochemical and Biophysical Research Communications·E McKenzieM Page
Feb 13, 2001·Trends in Cell Biology·J TurnbullS Guimond
Mar 16, 2001·Biochimica Et Biophysica Acta·C R ParishM D Hulett
Oct 26, 2001·Japanese Journal of Cancer Research : Gann·S MikamiM Koike
Jun 5, 2002·Annual Review of Biochemistry·Jeffrey D Esko, Scott B Selleck
Jul 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Orit GoldshmidtIsrael Vlodavsky
Apr 15, 2003·Cancer Letters·Siro SimizuHiroyuki Osada
Aug 21, 2003·Biochemical and Biophysical Research Communications·Flonia Levy-AdamNeta Ilan
Oct 3, 2003·The Journal of Biological Chemistry·Amanda M de MestreMark D Hulett
Oct 24, 2003·The Journal of Biological Chemistry·Siro SimizuHiroyuki Osada
Oct 31, 2003·Oncogene·Pesach J ShteperDina Ben-Yehuda
Feb 11, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eyal ZchariaIsrael Vlodavsky
May 5, 2004·Chemistry & Biology·Keisuke IshidaHiroyuki Osada
Nov 4, 2004·Integrative Cancer Therapies·Kenneth A Conklin

❮ Previous
Next ❯

Citations

Feb 11, 2011·Cancer Metastasis Reviews·Gil ArvatzIsrael Vlodavsky
Nov 21, 2007·Thrombosis Research·Israel VlodavskyRam Sasisekharan
Jan 11, 2007·Immunology and Cell Biology·Amanda M de MestreMark D Hulett
Dec 21, 2006·Molecular and Cellular Biology·Irina IssaevaEli Canaani
Jul 13, 2006·Annual Review of Biomedical Engineering·Ram SasisekharanVikas Prabhakar
Apr 24, 2009·Natural Product Reports·Sherket PetersonJian Liu
Feb 15, 2012·Cellular and Molecular Life Sciences : CMLS·Esther HermanoMichael Elkin
Jul 29, 2008·Connective Tissue Research·Israel VlodavskyNeta Ilan
Oct 20, 2006·Kidney International·M J van den HovenJ H Berden
Sep 8, 2009·Trends in Biochemical Sciences·Liat FuxIsrael Vlodavsky
Jul 30, 2008·Experimental Cell Research·Ngit Shin LaiHiroyuki Osada
Apr 17, 2008·International Journal of Dermatology·Xiao-Yan LiuHong-Chao Chen
Mar 7, 2007·British Journal of Pharmacology·E A McKenzie
Feb 13, 2013·The FEBS Journal·Amichay MeirovitzMichael Elkin
Aug 12, 2006·The International Journal of Biochemistry & Cell Biology·Neta IlanIsrael Vlodavsky
Mar 19, 2013·Matrix Biology : Journal of the International Society for Matrix Biology·Rachel GoldbergMichael Elkin
Apr 18, 2007·British Journal of Cancer·A C BackenG C Jayson
Feb 26, 2010·The Journal of Biological Chemistry·Sherket B Peterson, Jian Liu
Sep 23, 2020·Cardiovascular Engineering and Technology·Sheldon WeinbaumJohn M Tarbell
Sep 21, 2006·Molecular Cancer Therapeutics·George W YipMartin Götte
Aug 19, 2007·Cancer Research·Siro SimizuHiroyuki Osada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.